Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), March 2025 The Doxy-PEP Decision Making Tool supports prescribing doxycycline post-exposure prophylaxis (Doxy-PEP) to gay and bisexual men and transgender women at increased risk of syphilis. Suitable patients include those with recent syphilis or other STI diagnoses, periods of increased risk, or who wish to protect...
Khaw, C., Malden, C., Ratnayake, M. et al. Diagnosis and Management of Syphilis in Patients With HIV Co-infection. Curr Treat Options Infect Dis (2020). Published11 June 2020 Purpose of review Syphilis cases are on the increase especially in men who have sex with men (MSM) in urban areas of high-income countries. There is a strong association between syphilis and HIV infections. We review the...
ScienceDaily, December 23, 2015 In one of the most tightly controlled trials ever conducted of drugs used to treat sexually transmitted infections, researchers at the University of Alabama at Birmingham have confirmed that azithromycin remains effective in the treatment of urogenital chlamydia. In a study published Dec. 24 in the New England Journal of Medicine, the research team compared two of...
nam, 12 February 2015
A small pilot study using a daily dose of the antibiotic doxycycline as pre-exposure prophylaxis against sexually transmitted infections has found that a group of HIV-positive gay men taking doxycycline was more than 70% less likely to be infected with an STI than men given financial incentives to avoid STIs, a significant difference.
Read more here